BridgeBio Oncology Therapeutics (BBOT) Q4 2025 Earnings

12NovConfirmed
Q3 2025
Q4 2025
-49.62
-33.2
-16.79
-0.38

Details

Expected EPS
-0.381667
Actual EPS
-1.03
Surprise EPS
-0.65
Surprise Percent
+169.87%

Description

BridgeBio Oncology Therapeutics (BBOT) has reported earnings of -1.03 per share for Q4 2025.

0 Comments

Share your thoughts